Principal Financial Group Inc Jazz Pharmaceuticals PLC Transaction History

Principal Financial Group Inc

  • $176 Billion
  • Q2 2025

A detailed history of Principal Financial Group Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Principal Financial Group Inc holds 139,653 shares of JAZZ stock, worth $19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
139,653
Previous 139,041 0.44%
Holding current value
$19 Million
Previous $17.3 Million 14.15%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$97.78 - $126.44 $59,841 - $77,381
612 Added 0.44%
139,653 $14.8 Million
Q1 2025

Apr 28, 2025
BUY
$120.07 - $144.17 $45,386 - $54,496
378 Added 0.27%
139,041 $17.3 Million
Q4 2024

Jan 31, 2025
BUY
$107.32 - $127.74 $14.9 Million - $17.7 Million
138,663 New
138,663 $17.1 Million
Q3 2024

Oct 31, 2024
SELL
$100.57 - $116.37 $6.72 Million - $7.78 Million
-66,821 Reduced 31.86%
142,938 $15.9 Million
Q2 2024

Jul 29, 2024
SELL
$103.94 - $118.98 $2.88 Million - $3.29 Million
-27,684 Reduced 11.66%
209,759 $22.4 Million
Q1 2024

Apr 29, 2024
BUY
$115.19 - $132.77 $583,552 - $672,612
5,066 Added 2.18%
237,443 $28.6 Million
Q4 2023

Feb 07, 2024
SELL
$114.26 - $136.0 $203,268 - $241,944
-1,779 Reduced 0.76%
232,377 $28.6 Million
Q3 2023

Nov 02, 2023
SELL
$122.0 - $145.31 $900,482 - $1.07 Million
-7,381 Reduced 3.06%
234,156 $30.3 Million
Q2 2023

Aug 07, 2023
SELL
$122.5 - $147.16 $920,710 - $1.11 Million
-7,516 Reduced 3.02%
241,537 $29.9 Million
Q1 2023

May 09, 2023
BUY
$133.98 - $160.47 $298,373 - $357,366
2,227 Added 0.9%
249,053 $36.4 Million
Q4 2022

Feb 09, 2023
SELL
$129.72 - $159.85 $594,247 - $732,272
-4,581 Reduced 1.82%
246,826 $39.3 Million
Q3 2022

Nov 09, 2022
SELL
$126.59 - $161.18 $8.11 Million - $10.3 Million
-64,030 Reduced 20.3%
251,407 $33.5 Million
Q2 2022

Aug 10, 2022
BUY
$141.59 - $168.66 $10.1 Million - $12.1 Million
71,450 Added 29.28%
315,437 $49.2 Million
Q1 2022

May 09, 2022
BUY
$129.64 - $160.7 $4.38 Million - $5.43 Million
33,759 Added 16.06%
243,987 $38 Million
Q4 2021

Feb 09, 2022
SELL
$119.87 - $145.67 $313,460 - $380,927
-2,615 Reduced 1.23%
210,228 $26.8 Million
Q3 2021

Nov 09, 2021
SELL
$128.64 - $184.79 $7.26 Million - $10.4 Million
-56,449 Reduced 20.96%
212,843 $27.7 Million
Q2 2021

Aug 10, 2021
BUY
$160.2 - $186.42 $12 Million - $14 Million
75,134 Added 38.7%
269,292 $47.8 Million
Q1 2021

May 10, 2021
BUY
$150.19 - $173.5 $4.38 Million - $5.06 Million
29,142 Added 17.66%
194,158 $31.9 Million
Q4 2020

Feb 08, 2021
BUY
$140.71 - $165.05 $22,935 - $26,903
163 Added 0.1%
165,016 $27.2 Million
Q3 2020

Nov 06, 2020
BUY
$105.46 - $144.13 $16.9 Million - $23.1 Million
160,348 Added 3559.33%
164,853 $23.5 Million
Q2 2020

Aug 05, 2020
SELL
$95.68 - $121.88 $395,923 - $504,339
-4,138 Reduced 47.88%
4,505 $497,000
Q1 2020

May 12, 2020
BUY
$87.74 - $152.74 $97,566 - $169,846
1,112 Added 14.77%
8,643 $862,000
Q4 2019

Feb 05, 2020
BUY
$117.65 - $153.73 $106,473 - $139,125
905 Added 13.66%
7,531 $1.12 Million
Q3 2019

Nov 13, 2019
SELL
$125.18 - $143.24 $751 - $859
-6 Reduced 0.09%
6,626 $849,000
Q2 2019

Aug 12, 2019
SELL
$125.55 - $144.48 $281,357 - $323,779
-2,241 Reduced 25.26%
6,632 $945,000
Q1 2019

May 10, 2019
BUY
$121.81 - $142.95 $129,484 - $151,955
1,063 Added 13.61%
8,873 $1.27 Million
Q4 2018

Feb 14, 2019
SELL
$115.94 - $166.74 $162,547 - $233,769
-1,402 Reduced 15.22%
7,810 $968,000
Q3 2018

Nov 14, 2018
BUY
$161.01 - $180.57 $131,223 - $147,164
815 Added 9.71%
9,212 $1.55 Million
Q2 2018

Aug 13, 2018
BUY
$146.33 - $183.18 $1.23 Million - $1.54 Million
8,397 New
8,397 $0

Others Institutions Holding JAZZ

# of Institutions
565
Shares Held
62.3M
Call Options Held
563K
Put Options Held
79.8K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.54B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email